Quanticate Appoints President and Expands Services

Biometrics Company Quanticate Appoints Andrew MacGarvey to President of U.S. Operations Signaling Further Expansion of CRO Services

Cambridge, MA and London,UK–January 28, 2009 -Quanticate, a global biometrics clinical research organization (CRO) today announced that it has appointed Andrew MacGarvey as President of its U.S. operations headquartered in Cambridge, MA.  The position indicates the company’s mission to further expand its clinical trial service capabilities with MacGarvey managing the company’s initiatives in support of existing and new U.S. clients.  In addition, MacGarvey will continue to direct the company’s global sales efforts.

“The move to establishing a U.S. headquarters is in response to the terrific reception of our products by companies here in the States,” said MacGarvey.  “We have been handling clinical trials for our U.S. customers here and overseas for some time.  Our mission now is to grow the office and add more operational elements in line with our customers’ requirements.”

Prior to joining Quanticate, MacGarvey served as a Director at Datatrial, an EDC (Electronic Data Capture)-focused firm that delivers solutions to the clinical research community.   MacGarvey worked in an operational and commercial capacity, helping the company to expand its service offerings and launch its services into the U.S. market.  Additionally, he has held technology and operational positions at Omnicare, Statwood and PRA International. 

MacGarvey expects to see significant growth in the U.S., particularly with FDA pressures on biotech and pharmaceutical companies to provide more in-depth and complex data as they move through all phases of clinical trials.  “The market grew by 15% last year and this growth looks set to continue,” he noted.  “Much of the growth will be from U.S. companies conducting trials here and overseas.  With our ability to deliver services across three continents and our flexibility to adapt to any technology environment, I believe that Quanticate is in a very positive competitive position.”

About Quanticate
Quanticate, with headquarters in Cambridge, MA and London, UK, is the largest global biometrics company with full service clinical trial capabilities.  Trusted and respected throughout the industry, Quanticate delivers premium quality clinical trial services, consultancy, highly scalable on-and off-site data management, statistical programming and analysis, and medical writing solutions. Dedicated staff recruitment services are provided through Quanticate People. With resources spanning three continents, Quanticate is renowned for its dedication to clients, world-class service and superior results.  In working closely with biotech, pharmaceutical and medical device companies, Quanticate prides itself in being a seamless extension of its customers’ internal teams offering the flexibility to adapt to any technology environment.  For more information, visit www.quanticate.com.